Dagmar Schinnerl

ORCID: 0000-0003-4918-9302
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • CAR-T cell therapy research
  • Chronic Lymphocytic Leukemia Research
  • Immune Cell Function and Interaction
  • Acute Lymphoblastic Leukemia research
  • Chronic Myeloid Leukemia Treatments
  • Acute Myeloid Leukemia Research
  • Childhood Cancer Survivors' Quality of Life
  • Lymphoma Diagnosis and Treatment
  • T-cell and B-cell Immunology
  • Infection Control and Ventilation
  • Respiratory viral infections research
  • SARS-CoV-2 detection and testing
  • Genomic variations and chromosomal abnormalities
  • Molecular Biology Techniques and Applications
  • Cytomegalovirus and herpesvirus research
  • Renal and related cancers
  • Advanced biosensing and bioanalysis techniques
  • Genetics and Neurodevelopmental Disorders

St. Anna Children's Cancer Research Institute
2014-2024

St Anna Children's Hospital
2014-2024

University of Veterinary Medicine Vienna
2023

The mutational landscape of B-cell precursor acute lymphoblastic leukemia (BCP-ALL), the most common pediatric cancer, is not fully described partially because commonly applied short-read next generation sequencing has a limited ability to identify structural variations. By combining comprehensive analysis variants (SVs), single-nucleotide (SNVs), and small insertions-deletions, new subtype-defining therapeutic targets may be detected. We analyzed somatic alterations in 60 patients diagnosed...

10.1097/hs9.0000000000000925 article EN cc-by-nc-nd HemaSphere 2023-07-17

<div>Abstract<p>The term cancer immunoediting describes the dual role by which immune system can suppress and promote tumor growth is divided into three phases: elimination, equilibrium, escape. The of NK cells has mainly been attributed to elimination phase. Here, we show that play a in all phases immunoediting. Extended co-culturing DNA-barcoded mouse BCR/ABL<sup>p185+</sup> B-cell acute lymphoblastic leukemia (B-ALL) with allowed for quantitative measure...

10.1158/2326-6066.c.7702665 preprint EN 2025-03-04

Chromosome 21 is the most affected chromosome in childhood acute lymphoblastic leukemia. Many of its numerical and structural abnormalities define diagnostically clinically important subgroups. To obtain an overview about their types approximate genetic subgroup-specific incidence distribution, we performed cytogenetic, FISH array analyses a total 578 ALL patients (including 26 with constitutional trisomy 21). The latter preferred method to assess genome-wide large fine-scale copy number...

10.3390/cancers13184597 article EN Cancers 2021-09-13

A heterogeneous genetic subtype of B-cell precursor acute lymphoblastic leukemia is driven by constitutive kinase-activation, including patients with JAK2 fusions. In our study, we model the impact a novel fusion protein on hematopoietic development in human induced pluripotent stem cells (hiPSCs). We insert RUNX1-JAK2 into one endogenous RUNX1 allele through employing trans paired nicking genome editing. Tagging degron facilitates depletion using heterobifunctional compound dTAG-13....

10.3390/ijms22147576 article EN International Journal of Molecular Sciences 2021-07-15

Abstract The term cancer immunoediting describes the dual role by which immune system can suppress and promote tumour growth is divided into three phases: elimination, equilibrium escape. of NK cells has mainly been attributed to elimination phase. Here we show that play a in all phases immunoediting. Extended co-culturing DNA barcoded mouse BCR/ABLp185+ B-cell acute lymphoblastic leukaemia (B-ALL) with allowed for quantitative measure cell–mediated Although most cell clones were efficiently...

10.1158/2326-6066.cir-24-0189 article EN Cancer Immunology Research 2024-12-06
Coming Soon ...